Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Treatment of secondary CNS lymphoma using CD19-targeted chimeric antigen receptor (CAR) T cells.

Autor: Kline K; Cancer Immunotherapy, Fannie Angelos Cellular Therapeutics GMP Laboratory, University of Maryland Greenebaum Comprehensive Cancer Center, Bressler Research Building, Room 9-011, 655 W. Baltimore Street, Baltimore, MD, 21201, USA.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA., Luetkens T; Cancer Immunotherapy, Fannie Angelos Cellular Therapeutics GMP Laboratory, University of Maryland Greenebaum Comprehensive Cancer Center, Bressler Research Building, Room 9-011, 655 W. Baltimore Street, Baltimore, MD, 21201, USA.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.; Department of Microbiology and Immunology, University of Maryland, Baltimore, MD, USA., Koka R; Department of Pathology, University of Maryland School of Medicine, Baltimore, MD, USA., Kallen ME; Department of Pathology, University of Maryland School of Medicine, Baltimore, MD, USA., Chen W; Diagnostic Radiology and Nuclear Medicine, University of Maryland School of Medicine, Baltimore, MD, USA., Ahmad H; Cancer Immunotherapy, Fannie Angelos Cellular Therapeutics GMP Laboratory, University of Maryland Greenebaum Comprehensive Cancer Center, Bressler Research Building, Room 9-011, 655 W. Baltimore Street, Baltimore, MD, 21201, USA.; Department of Neurology, University of Maryland School of Medicine, Baltimore, MD, USA., Omili D; Cancer Immunotherapy, Fannie Angelos Cellular Therapeutics GMP Laboratory, University of Maryland Greenebaum Comprehensive Cancer Center, Bressler Research Building, Room 9-011, 655 W. Baltimore Street, Baltimore, MD, 21201, USA.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA., Iraguha T; Cancer Immunotherapy, Fannie Angelos Cellular Therapeutics GMP Laboratory, University of Maryland Greenebaum Comprehensive Cancer Center, Bressler Research Building, Room 9-011, 655 W. Baltimore Street, Baltimore, MD, 21201, USA.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA., Gebru E; Cancer Immunotherapy, Fannie Angelos Cellular Therapeutics GMP Laboratory, University of Maryland Greenebaum Comprehensive Cancer Center, Bressler Research Building, Room 9-011, 655 W. Baltimore Street, Baltimore, MD, 21201, USA.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA., Fan X; Cancer Immunotherapy, Fannie Angelos Cellular Therapeutics GMP Laboratory, University of Maryland Greenebaum Comprehensive Cancer Center, Bressler Research Building, Room 9-011, 655 W. Baltimore Street, Baltimore, MD, 21201, USA.; Department of Microbiology and Immunology, University of Maryland, Baltimore, MD, USA., Miller A; Department of Pathology, University of Maryland School of Medicine, Baltimore, MD, USA., Dishanthan N; Cancer Immunotherapy, Fannie Angelos Cellular Therapeutics GMP Laboratory, University of Maryland Greenebaum Comprehensive Cancer Center, Bressler Research Building, Room 9-011, 655 W. Baltimore Street, Baltimore, MD, 21201, USA.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA., Baker JM; Department of Microbiology and Immunology, University of Maryland, Baltimore, MD, USA., Dietze KA; Department of Microbiology and Immunology, University of Maryland, Baltimore, MD, USA., Hankey KG; Cancer Immunotherapy, Fannie Angelos Cellular Therapeutics GMP Laboratory, University of Maryland Greenebaum Comprehensive Cancer Center, Bressler Research Building, Room 9-011, 655 W. Baltimore Street, Baltimore, MD, 21201, USA.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA., Yared JA; Cancer Immunotherapy, Fannie Angelos Cellular Therapeutics GMP Laboratory, University of Maryland Greenebaum Comprehensive Cancer Center, Bressler Research Building, Room 9-011, 655 W. Baltimore Street, Baltimore, MD, 21201, USA.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA., Hardy NM; Cancer Immunotherapy, Fannie Angelos Cellular Therapeutics GMP Laboratory, University of Maryland Greenebaum Comprehensive Cancer Center, Bressler Research Building, Room 9-011, 655 W. Baltimore Street, Baltimore, MD, 21201, USA.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA., Rapoport AP; Cancer Immunotherapy, Fannie Angelos Cellular Therapeutics GMP Laboratory, University of Maryland Greenebaum Comprehensive Cancer Center, Bressler Research Building, Room 9-011, 655 W. Baltimore Street, Baltimore, MD, 21201, USA.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA., Dahiya S; Cancer Immunotherapy, Fannie Angelos Cellular Therapeutics GMP Laboratory, University of Maryland Greenebaum Comprehensive Cancer Center, Bressler Research Building, Room 9-011, 655 W. Baltimore Street, Baltimore, MD, 21201, USA.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Stanford University, Stanford, CA, USA., Atanackovic D; Cancer Immunotherapy, Fannie Angelos Cellular Therapeutics GMP Laboratory, University of Maryland Greenebaum Comprehensive Cancer Center, Bressler Research Building, Room 9-011, 655 W. Baltimore Street, Baltimore, MD, 21201, USA. datanackovic@som.umaryland.edu.; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA. datanackovic@som.umaryland.edu.; Department of Microbiology and Immunology, University of Maryland, Baltimore, MD, USA. datanackovic@som.umaryland.edu.; Transplant and Cellular Therapy Program, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA. datanackovic@som.umaryland.edu.

Publikováno v: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2024 Feb 13; Vol. 73 (3), pp. 45. Date of Electronic Publication: 2024 Feb 13.

Ocular adverse events associated with chimeric antigen receptor T-cell therapy: a case series and review.

Autor: Mumtaz AA; Department of Ophthalmology and Visual Sciences, University of Maryland School of Medicine, Baltimore, Maryland, USA., Fischer A; Department of Ophthalmology and Visual Sciences, University of Maryland School of Medicine, Baltimore, Maryland, USA., Lutfi F; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland - Baltimore, University of Maryland School of Medicine, Baltimore, Maryland, USA., Matsumoto LR; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland - Baltimore, University of Maryland School of Medicine, Baltimore, Maryland, USA., Atanackovic D; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland - Baltimore, University of Maryland School of Medicine, Baltimore, Maryland, USA., Kolanci ET; Department of Ophthalmology and Visual Sciences, University of Maryland School of Medicine, Baltimore, Maryland, USA., Hankey KG; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland - Baltimore, University of Maryland School of Medicine, Baltimore, Maryland, USA., Hardy NM; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland - Baltimore, University of Maryland School of Medicine, Baltimore, Maryland, USA., Yared JA; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland - Baltimore, University of Maryland School of Medicine, Baltimore, Maryland, USA., Kocoglu MH; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland - Baltimore, University of Maryland School of Medicine, Baltimore, Maryland, USA., Rapoport AP; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland - Baltimore, University of Maryland School of Medicine, Baltimore, Maryland, USA., Dahiya S; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland - Baltimore, University of Maryland School of Medicine, Baltimore, Maryland, USA., Li AS; Vitreoretinal Consultants of New York, Northwell Health Eye Institute, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, USA., Sunshine SB; Department of Ophthalmology and Visual Sciences, University of Maryland School of Medicine, Baltimore, Maryland, USA ssunshine@som.umaryland.edu.; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland - Baltimore, University of Maryland School of Medicine, Baltimore, Maryland, USA.

Publikováno v: The British journal of ophthalmology [Br J Ophthalmol] 2023 Jul; Vol. 107 (7), pp. 901-905. Date of Electronic Publication: 2022 Feb 10.

Deep dissection of the antiviral immune profile of patients with COVID-19.

Autor: Atanackovic D; Transplant and Cellular Therapy Program, Department of Medicine, University of Maryland School of Medicine and Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA. datanackovic@som.umaryland.edu.; Department of Microbiology and Immunology, University of Maryland, Baltimore, MD, USA. datanackovic@som.umaryland.edu., Avila SV; Transplant and Cellular Therapy Program, Department of Medicine, University of Maryland School of Medicine and Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA., Lutfi F; University of Maryland School of Medicine and Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA., de Miguel-Perez D; University of Maryland School of Medicine and Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA., Fan X; University of Maryland School of Medicine and Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA., Sanchez-Petitto G; University of Maryland School of Medicine and Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA., Vander Mause E; Transplant and Cellular Therapy Program, Department of Medicine, University of Maryland School of Medicine and Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA., Siglin J; University of Maryland School of Medicine and Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA., Baddley J; Division of Infectious Diseases, University of Maryland School of Medicine and Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA., Mannuel HD; Hematology/Oncology, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Baltimore Veterans Affairs Medical Center, Baltimore, MD, USA., Alkhaldi H; University of Maryland School of Medicine and Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA., Hankey KG; Transplant and Cellular Therapy Program, Department of Medicine, University of Maryland School of Medicine and Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA., Lapidus R; University of Maryland School of Medicine and Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA., Kleinberg M; Division of Infectious Diseases, University of Maryland School of Medicine and Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA., Rabin J; R. Adams Cowley Shock Trauma Center, Department of Surgery, University of Maryland School of Medicine, Baltimore, MD, USA., Shanholtz C; Division of Pulmonary and Critical Care Medicine, University of Maryland School of Medicine, Baltimore, MD, USA., Rolfo C; University of Maryland School of Medicine and Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA., Rapoport AP; Transplant and Cellular Therapy Program, Department of Medicine, University of Maryland School of Medicine and Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA., Dahiya S; Transplant and Cellular Therapy Program, Department of Medicine, University of Maryland School of Medicine and Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA., Luetkens T; Transplant and Cellular Therapy Program, Department of Medicine, University of Maryland School of Medicine and Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Department of Microbiology and Immunology, University of Maryland, Baltimore, MD, USA.

Publikováno v: Communications biology [Commun Biol] 2021 Dec 16; Vol. 4 (1), pp. 1389. Date of Electronic Publication: 2021 Dec 16.

AEOL 10150 Alleviates Radiation-induced Innate Immune Responses in Non-human Primate Lung Tissue.

Autor: Cui W, Zhang P; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD 21201., Hankey KG; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD 21201., Xiao M; Armed Forces Radiobiology Research Institute, Uniformed Services University of the Health Sciences, Bethesda, MD 20889., Farese AM; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD 21201., MacVittie TJ; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD 21201.

Publikováno v: Health physics [Health Phys] 2021 Oct 01; Vol. 121 (4), pp. 331-344.